课题基金 / 基金详情

PROTEOGLYCANS IN NORMAL AND SCARRED CORNEAS

PROTEOGLYCANS IN NORMAL AND SCARRED CORNEAS
正常角膜和疤痕角膜中的蛋白聚糖
批准号:
2162980
负责人:
JAMES L FUNDERBURGH
金额:
$13.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1998-07-31

项目摘要

项目成果

JAMES L FUNDERBURGH的其他基金

相似基金

相关文献

中文摘要
翻译
角膜疤痕限制了全球数亿人的视力。 疤痕有多种病因,但通常是永久性的和可矫正的。 只能通过手术。这项研究的长期目标是确定 角膜瘢痕组织的物理、生物学特性及临床意义 控制其形成的条件。蛋白多糖构成了一种主要的 间质的成分和适当的蛋白多糖组成出现 对于角膜透明来说是必不可少的。有一个明显的变化,在 瘢痕组织与正常组织的蛋白多糖组成比较; 然而,疤痕蛋白多糖的性质还没有很好的定义。模特是 提出了蛋白多糖在瘢痕组织生物学中的作用 基于我们目前对细胞外基质生物学的了解。 对基于该模型的假设进行测试的实验旨在 完成四个具体目标:(1)比较正常和正常的蛋白多糖 在蛋白多糖分子类型方面,人的角膜有疤痕。(2)界定 角膜蛋白多糖与其他生化物质的特异性相互作用 角膜细胞外基质的成分。(3)检验生物 蛋白多糖的活性(4)决定调节瘢痕组织的因素 由角质形成细胞合成。对于第一个目的,抗体将被用来 确定蛋白多糖蛋白核心的丰度和同一性 组织切片和伤痕累累的人角膜提取液中。凝集素 而针对这些分子碳水化合物部分的抗体将 用来定义它们的糖基化状态。在目标2和3中,纯净 蛋白多糖,代表那些在疤痕和正常中被鉴定的 间质,将被检查与细胞外的特定相互作用 基质分子和瘢痕组织细胞。的状态的影响 核心蛋白中特定氨基酸序列的糖基化 通过使用脱糖蛋白和重组蛋白进行评估 含有部分核心蛋白质的。我们将研究互动 胶原蛋白、层粘连蛋白、转化生长因子β、角质形成细胞和 巨噬细胞,评估蛋白多糖结合及其生物学效应 装订。在第四个目标中,一种影响角质形成细胞的可溶性因素 功能将被提纯和表征。这些实验将 为我们理解角膜疤痕生物学提供必要的知识 以及我们控制这一病理过程的能力。
英文摘要
Corneal scars limit vision for hundreds of millions of persons worldwide. Scarring has a diverse etiology but is usually permanent and correctable only by surgery. The long-range goal of this research to determine the physical and biological properties of corneal scar tissue and the conditions that control its formation. Proteoglycans constitute a major component of the stroma and proper proteoglycan composition appears essential for corneal transparency. There is a marked alteration in the proteoglycan composition of scar tissue compared to that of normal tissue; however, the nature of scar proteoglycans is not well defined. A model is presented proposing roles for proteoglycans in the biology of scar tissue based on our current knowledge of extracellular matrix biology. Experiments, testing hypotheses based on this model, are designed to accomplish four specific aims: (1) Compare proteoglycans of normal and scarred human corneas in terms of proteoglycan molecular types. (2) Define specific interactions between corneal proteoglycans and other biochemical components of the corneal extracellular matrix. (3) Examine the biological activity of proteoglycans (4) Determine factors regulating scar tissue synthesis by keratocytes. For the first aim, antibodies will be used to determine the abundance and identity of proteoglycan protein cores in histological sections and in extracts of scarred human corneas. Lectins and antibodies against the carbohydrate portions of these molecules will be used to define their state of glycosylation. In aim 2 & 3, purified proteoglycans, representative of those identified in scarred and normal stroma, will be examined for specific interactions with extracellular matrix molecules and with cells of scar tissue. Effect of the state of glycosylation and of specific amino acid sequence in the core protein will be assessed by use of deglycosylated proteins and of recombinant-proteins containing portions of the core proteins. Interactions will be examined with collagens, laminin, transforming growth factor beta, keratocytes, and macrophages, assessing proteoglycan binding and the biological effects of the binding. In the fourth aim, a soluble factor affecting keratocyte function will be purified and characterized. These experiments will provide knowledge essential to our understanding of corneal scar biology and to our ability to control this pathological process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioengineering Cornea with Autologous Stem Cells
A Pluripotent Stem Cell Reagent for Corneal Regeneration
A Pluripotent Stem Cell Reagent for Corneal Regeneration
Stem Cells for Corneal Engineering
海外基金